Authors

• Bram Ruijsink (ORCID: https://orcid.org/0000-0001-8313-5709)
• Amand F. Schmidt (ORCID: https://orcid.org/0000-0003-1327-0424)
• Jessica van Setten (ORCID: https://orcid.org/0000-0002-4934-7510)
• Folkert W. Asselbergs (ORCID: https://orcid.org/0000-0002-1692-8669)
• B. K. Velthuis
• Mimount Bourfiss (ORCID: https://orcid.org/0000-0001-5820-4610)
• Abdulrahman Alasiri (ORCID: https://orcid.org/0000-0003-1450-2936)
• Esther Puyol‐Antón (ORCID: https://orcid.org/0000-0002-9789-6629)
• Chris Finan (ORCID: https://orcid.org/0000-0002-3319-1937)
• Anneline S.J.M. te Riele (ORCID: https://orcid.org/0000-0002-4694-4790)

Institutions

• King's College London (GB)
• King Saud bin Abdulaziz University for Health Sciences (SA)
• Utrecht University (NL)
• University Medical Center Utrecht (NL)
• King Abdullah International Medical Research Center (SA)
• Netherlands Heart Institute (NL)
• Kings Health Partners (GB)
• UCL Biomedical Research Centre (GB)
• Health Data Research UK (GB)
• University College London (GB)
• National Guard Health Affairs (SA)
• University of Amsterdam (NL)

Publication Details

Journal

Communications Medicine

Published

2025-04-19

DOI

https://doi.org/10.1038/s43856-025-00855-1

Citations

3

Primary Topic

Cardiovascular Function and Risk Factors

Type

article

Field-Weighted Citation Impact

4.16

Funders

• Wellcome Trust
• European Federation of Pharmaceutical Industries and Associations
• Government of the United Kingdom
• UK Research and Innovation
• National Institute for Health and Care Research
• British Heart Foundation
• University College London
• Rosetrees Trust
• ZonMw
• Nederlandse Organisatie voor Wetenschappelijk Onderzoek
• Northwest Regional Development Agency
• National Institutes of Health
• HORIZON EUROPE Framework Programme
• Medical Research Council